Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Ecotoxicol Environ Saf ; 256: 114835, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-37003058

RESUMO

Bioplastics derived from organic materials other than crude oil are often suggested as sustainable solutions for tackling end-of-life plastic waste, but little is known of their ecotoxicity to aquatic species. Here, we investigated the ecotoxicity of second and third generation bioplastics toward the freshwater zooplankton Daphnia magna. In acute toxicity tests (48 h), survival was impacted at high concentrations (g.L-1 range), within the range of salinity-induced toxicity. Macroalgae-derived bioplastic induced hormetic responses under chronic exposure (21 d). Most biological traits were enhanced from 0.06 to 0.25 g.L-1 (reproduction rate, body length, width, apical spine, protein concentration), while most of these traits returned to controls level at 0.5 g.L-1. Phenol-oxidase activity, indicative of immune function, was enhanced only at the lowest concentration (0.06 g.L-1). We hypothesise these suggested health benefits were due to assimilation of carbon derived from the macroalgae-based bioplastic as food. Polymer identity was confirmed by infra-red spectroscopy. Chemical analysis of each bioplastic revealed low metal abundance whilst non target exploration of organic compounds revealed trace amounts of phthalates and flame retardants. The macroalgae-bioplastic disintegrated completely in compost and biodegraded up to 86 % in aqueous medium. All bioplastics acidified the test medium. In conclusion, the tested bioplastics were classified as environmentally safe. Nonetheless, a reasonable end-of-life management of these safer-by-design materials is advised to ensure the absence of harmful effects at high concentrations, depending on the receiving environment.


Assuntos
Plásticos , Poluentes Químicos da Água , Animais , Plásticos/química , Polímeros , Biopolímeros/farmacologia , Metais/farmacologia , Testes de Toxicidade Aguda , Daphnia , Poluentes Químicos da Água/toxicidade
2.
Int J Biol Macromol ; 165(Pt A): 1507-1518, 2020 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-33038402

RESUMO

The study demonstrates the use of chitosan as a carrier agent of designed antifungal formulation (CME 4:1:1) based on a combination of plant compounds such as trans- cinnamaldehyde (C), methyl eugenol (M), and estragole (E). The formulation was encapsulated inside the chitosan biopolymer nanomatrix (Ne-CME) and characterized by SEM, FTIR, and XRD. The Ne-CME exhibited enhanced antifungal and aflatoxin B1 inhibitory effect compared to the individual compounds and unencapsulated form. Ne-CME (0.04 µl/ml) caused significant protection of Piper longum fruit from fungal (90.05%) and aflatoxin B1 (100%) contamination and had no significant negative effects on its nutritional properties. In addition, the probable antifungal mechanism of Ne-CME was investigated using in-silico (effect on Omt-1 and Vbs structural genes of AFB1 biosynthesis) and biochemical (perturbances in the cell membrane, carbohydrate catabolism, methyl-glyoxal, mitochondrial membrane potential, and antioxidant defense system) assay.


Assuntos
Aflatoxina B1/antagonistas & inibidores , Antifúngicos/química , Quitosana/química , Nanopartículas/química , Aflatoxina B1/toxicidade , Antifúngicos/farmacologia , Antioxidantes/química , Antioxidantes/farmacologia , Aspergillus flavus/efeitos dos fármacos , Aspergillus flavus/patogenicidade , Biopolímeros/química , Biopolímeros/farmacologia , Quitosana/farmacologia , Óleos Voláteis/química , Óleos Voláteis/farmacologia , Piper/efeitos dos fármacos , Piper/microbiologia
3.
J Sci Food Agric ; 97(6): 1846-1853, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27491506

RESUMO

BACKGROUND: The use of biopolymer coatings appears as a good alternative to preserve highly perishable fruits, as well as the environment. Proteins generally produce films with good mechanical properties, although their highly hydrophilic nature limits the use in many applications. Nanoparticles, such as nanoclays, can play a critical role in improving barrier properties. The present study evaluated the effect of the addition of montmorillonite (MMT)-nanoparticles to a lacto-biopolymer coating, focusing on: (i) the morphological, thermal and barrier properties of the material and (ii) the shelf life of coated fresh strawberries. RESULTS: The addition of MMT improved the water vapor barrier property. Morphological and thermal analysis indicated a good interaction between the milk protein and the nanoclay, which was intercalated within the milk protein base (MPB) matrix, offering a more tortuous path to diffusing migrants. The MMT-MPB coating helped to significantly (P ≤ 0.05) reduce the weight loss, as well as oxygen uptake and the release of carbon dioxide, and improved the fruit firmness and reduced mould and yeast load compared to the uncoated fruits. The addition of MMT gave statistical difference (P ≤ 0.05) in terms of weight loss, subjective global appearance and purchase intention of coated fresh strawberries. CONCLUSION: The addition of nanofillers, such as MMT, into protein-based coating could improve its water vapour barrier and could affect, positively, some parameters of the shelf life of coated strawberries. © 2016 Society of Chemical Industry.


Assuntos
Bentonita/farmacologia , Biopolímeros/farmacologia , Conservação de Alimentos/métodos , Conservantes de Alimentos/farmacologia , Fragaria/química , Frutas/química , Conservação de Alimentos/instrumentação , Fragaria/microbiologia , Frutas/microbiologia , Fungos/efeitos dos fármacos , Fungos/crescimento & desenvolvimento
4.
J Biomater Appl ; 12(1): 31-56, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9285329

RESUMO

The kinetics of controlled release of basic fibroblast growth factor (bFGF) from polymers (sutures, polycarbonate, Hydron, and Elvax), biopolymers (alginate), and biomatrices (lens capsules), and conditions for storage of bFGF (temperature, plastic type, heparin) were evaluated in vitro. Tissue culture proliferation bioassays with 3T3 fibroblasts, showed that only lens capsules with bFGF had a sustained release of bFGF for up to three weeks. The other materials released all of the 'bound' bFGF with two hours or produced an inflammatory response in vivo. Therefore, the lens tissue had the most potential for controlled long-term delivery of bFGF in vivo. These studies emphasise the importance of in vitro analysis of release kinetics of growth factors from a range of materials as a basis for potential in vivo applications.


Assuntos
Biopolímeros/metabolismo , Fator 2 de Crescimento de Fibroblastos/farmacocinética , Células 3T3/efeitos dos fármacos , Alginatos/metabolismo , Alginatos/farmacologia , Animais , Biopolímeros/farmacologia , Divisão Celular/efeitos dos fármacos , Fator 2 de Crescimento de Fibroblastos/farmacologia , Congelamento , Ácido Glucurônico , Ácidos Hexurônicos , Hidrogéis , Teste de Materiais/estatística & dados numéricos , Camundongos , Cimento de Policarboxilato/metabolismo , Cimento de Policarboxilato/farmacologia , Poli-Hidroxietil Metacrilato/análogos & derivados , Poli-Hidroxietil Metacrilato/metabolismo , Poli-Hidroxietil Metacrilato/farmacologia , Polivinil/metabolismo , Polivinil/farmacologia , Suturas
5.
Mol Med Today ; 3(2): 69-75, 1997 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9060004

RESUMO

Vaccines produced by recombinant DNA technology are safer than 'traditional' vaccines but they are often poorly immunogenic, requiring adjuvants to enhance their immunogenicity. Particulate adjuvants of defined dimensions (< 5 microns) have been shown to be effective in enhancing the immunogenicity of 'weak' antigens in animal models. Two novel adjuvants that possess significant potential for the development of new vaccines are the MF59 sub-microemulsion and polymeric microparticles. MF59 is an oil-in-water emulsion and has been shown to be both potent and safe in human subjects with several vaccines. Microparticles prepared from the biodegradable polymer poly(lactide-co-glycolide) have been shown to enhance immunogenicity when administered by mucosal routes, such as oral and intranasal, and they also possess considerable potential for the development of single-dose vaccines through the use of controlled-release technology.


Assuntos
Adjuvantes Imunológicos/farmacologia , Biopolímeros/química , Polissorbatos/farmacologia , Esqualeno/farmacologia , Vacinas Sintéticas/química , Vacinas Sintéticas/farmacologia , Adjuvantes Imunológicos/química , Adjuvantes Imunológicos/economia , Administração Intranasal , Animais , Biopolímeros/farmacologia , Biotecnologia/economia , Biotecnologia/métodos , Humanos , Imunidade nas Mucosas , Polissorbatos/química , Esqualeno/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA